Valiant Laboratories Limited

₹ CrorePeersALBERTDAVD HALEOSLABS ZIMLAB MEDICO MEDICAMEQ ANUHPHR AHCL WANBURY

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	50.1	48.3	227.0	227.0
+ Capital Work-in-Progress	42.6	155.8	6.1	6.1
+ Other Intangibles	0.0	0.1	0.1	0.1
+ Other Non-current Financial Assets	3.4	3.6	2.4	2.4
Non-current Financial Assets	3.4	3.6	2.4	2.4
+ Other Non-current Assets	21.0	0.5	0.0	0.0
Total Non-current Assets	117.1	208.2	235.7	235.7
Current Assets
+ Inventories	10.0	4.0	45.4	45.4
+ Current Investments	37.6	0.0	26.1	26.1
+ Trade Receivables	45.7	72.1	93.6	93.6
+ Cash & Cash Equivalents	11.7	4.9	3.5	3.5
+ Other Bank Balances	94.5	71.1	3.5	3.5
+ Short-term Loans	0.0	0.1	0.0	0.0
Current Financial Assets	189.6	148.2	126.8	126.8
+ Other Current Assets	21.9	38.3	54.5	54.5
Total Current Assets	225.5	192.6	228.3	228.3
Total Assets	342.7	400.9	464.0	464.0
Equity
+ Equity Share Capital	43.5	43.5	54.3	54.3
+ Other Equity / Reserves	193.4	190.9	256.6	256.6
Equity — Owners of Parent	236.9	234.3	310.9	310.9
Total Equity	236.9	234.3	310.9	310.9
Liabilities
+ Borrowings — Non-current	74.7	104.3	28.1	28.1
+ Other Non-current Financial Liab	1.4	1.2	1.8	1.8
Non-current Financial Liabilities	76.1	105.6	29.9	29.9
+ Provisions — Non-current	0.1	0.1	0.1	0.1
+ Deferred Tax Liabilities	0.6	1.2	3.6	3.6
Non-current Liabilities	76.7	106.9	33.6	33.6
+ Borrowings — Current	1.4	16.9	16.9	16.9
+ Trade Payables	25.9	40.7	94.0	94.0
+ Other Current Financial Liab	1.4	1.6	2.7	2.7
Current Financial Liabilities	28.8	59.2	113.6	113.6
+ Provisions — Current	0.1	0.2	0.3	0.3
+ Other Current Liabilities	0.2	0.3	5.5	5.5
Current Liabilities	29.1	59.6	119.4	119.4
Total Liabilities	105.8	166.5	153.1	153.1
Total Equity & Liabilities	342.7	400.9	464.0	464.0
Assets — additional as-filed lines
+ Current Tax Assets	4.1	2.2	1.7	1.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	3.8	2.9	2.9
+ Dues to Other Creditors — Current	—	36.9	91.1	91.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.